BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio
Acquiring Company
BioAdaptives
Acquired Company
Xycota Biosciences
Las VegasWyomingManufacturingBiotechnologyFood and BeverageHealth CareDietary SupplementsNutritionBiotechnologyHealth CareTherapeuticsDescription
On October 29, 2026, BioAdaptives, Inc. entered into a Membership Interest Purchase Agreement to acquire Xycota Biosciences LLC. This acquisition will result in Xycota becoming a wholly owned subsidiary of BioAdaptives. Xycota develops innovative CNS product candidates aimed at addressing PTSD and frontotemporal dementia. The transaction is subject to the satisfaction of certain closing conditions.
Who to call at BioAdaptives, and when
When BioAdaptives changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day BioAdaptives raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioAdaptives, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioAdaptives. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioAdaptives makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Xycota Biosciences?
Xycota Biosciences was acquired by BioAdaptives, based in Las Vegas. The deal was reported on November 4, 2026. BioAdaptives, Inc. is a leader in the nutritional products industry, committed to delivering innovative solutions that enhance quality of life, anti-aging, cell repair, and well-being. BioAdaptives is publicly traded (BDPT) and operates in Manufacturing.
When did BioAdaptives acquire Xycota Biosciences?
BioAdaptives's acquisition of Xycota Biosciences was reported on November 4, 2026. On October 29, 2026, BioAdaptives, Inc. entered into a Membership Interest Purchase Agreement to acquire Xycota Biosciences LLC. This acquisition will result in Xycota becoming a wholly owned subsidiary of BioAdaptives. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Xycota Biosciences do?
Xycota Biosciences LLC is a Wyoming-based preclinical biotechnology company. It is focused on developing central-nervous-system (CNS) product candidates, including psilocybin and psilocin-based treatments for PTSD and frontotemporal dementia. It is privately held, operating in Biotechnology, and is based in Wyoming.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.